Gary Shapiro
Company: Affini-T Therapeutics
Job title: Vice President Discovery Biology
Seminars:
Affini-T Platform Technologies Enable the Generation of Potent & Tolerable TCR-T Cells 11:00 am
TAILOR TCR discovery platform uses predictive algorithms to identify highly functional and specific TCRs against diverse targets TUNE Synthetic Biology platform programs cell persistence in the TME to enhance durability with switch receptors, co-receptor, and other armoring technologies THRIVE Engineering and Manufacturing platform allows for scalable manufacturing with gene editing technologies to generate a robust…Read more
day: Post-Conference Day - Tackling Solid Tumors